Follow
Amir Vajdi
Title
Cited by
Cited by
Year
Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway
KJ Kurppa, Y Liu, C To, T Zhang, M Fan, A Vajdi, EH Knelson, Y Xie, ...
Cancer cell 37 (1), 104-122. e12, 2020
3372020
Diminished efficacy of programmed death-(ligand) 1 inhibition in STK11-and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status
B Ricciuti, KC Arbour, JJ Lin, A Vajdi, N Vokes, L Hong, J Zhang, ...
Journal of Thoracic Oncology 17 (3), 399-410, 2022
1992022
Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity
NR Mahadevan, EH Knelson, JO Wolff, A Vajdi, M Saigí, M Campisi, ...
Cancer discovery 11 (8), 1952-1969, 2021
1022021
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade
K Sehgal, A Portell, EV Ivanova, PH Lizotte, NR Mahadevan, JR Greene, ...
The Journal of clinical investigation 131 (2), 2021
432021
Plasticity in the absence of NOTCH uncovers a RUNX2-dependent pathway in small cell lung cancer
D Hong, EH Knelson, Y Li, YT Durmaz, W Gao, E Walton, A Vajdi, T Thai, ...
Cancer research 82 (2), 248-263, 2022
222022
Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment
PM Szabo, A Vajdi, N Kumar, MY Tolstorukov, BJ Chen, R Edwards, ...
Scientific reports 13 (1), 3051, 2023
182023
Human gait database for normal walk collected by smartphone accelerometer
A Vajdi, MR Zaghian, NR Dehkordi, E Rastegari, K Maroofi, S Farahmand, ...
arXiv preprint arXiv:1905.03109, 2019
172019
The Extracellular Milieu of Toxoplasma's Lytic Cycle Drives Lab Adaptation, Primarily by Transcriptional Reprogramming
VA Primo Jr, Y Rezvani, A Farrell, CQ Murphy, J Lou, A Vajdi, GT Marth, ...
Msystems 6 (6), e01196-21, 2021
152021
Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1
HY Chen, YT Durmaz, Y Li, AH Sabet, A Vajdi, T Denize, E Walton, ...
Nature communications 13 (1), 4998, 2022
132022
MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer
R Yoshida, M Saigi, T Tani, BF Springer, H Shibata, S Kitajima, ...
Cancer research 82 (21), 4079-4092, 2022
112022
Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status.
B Ricciuti, KC Arbour, JJ Lin, N Vokes, A Vajdi Hoojghan, YY Li, ...
Journal of Clinical Oncology 38 (15_suppl), e15113-e15113, 2020
112020
A new dp algorithm for comparing gene expression data using geometric similarity
A Vajdi, N Haspel, H Banaee
2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2015
112015
Patch-DCA: improved protein interface prediction by utilizing structural information and clustering DCA scores
A Vajdi, K Zarringhalam, N Haspel
Bioinformatics 36 (5), 1460-1467, 2020
102020
Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC.
CM Rudin, HR Kim, A Navarro, M Gottfried, S Peters, T Csoszi, ...
Journal of Clinical Oncology 41 (16_suppl), 8503-8503, 2023
82023
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells
C Noyes, S Kitajima, F Li, Y Suita, S Miriyala, S Isaac, N Ahsan, E Knelson, ...
Communications Biology 6 (1), 65, 2023
82023
Clustering protein conformations using a dynamic programming based similarity measurement
A Vajdi, N Haspel
8th International Conference on Bioinformatics and Computational Biology …, 2016
62016
Integrating co-evolutionary information in monte carlo based method for proteins trajectory simulation
A Vajdi, A Joshi, N Haspel
Proceedings of the 10th ACM International Conference on Bioinformatics …, 2019
52019
Detecting chromosomal structural variation using jaccard distance and parallel architecture
H Mohebbi, A Vajdi, N Haspel, D Simovici
2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2017
52017
P14. 26 diminished efficacy of PD-(L) 1 inhibition in STK11-and KEAP1-Mutant lung adenocarcinoma is impacted by KRAS mutation status
B Ricciuti, K Arbour, J Lin, A Vajdi, M Tolstorukov, L Hong, J Zhang, ...
Journal of Thoracic Oncology 16 (3), S341, 2021
42021
Diminished efficacy of PD-(L) 1 inhibition in STK11-and KEAP1-mutant lung adenocarcinoma is impacted by KRAS mutation status
B Ricciuti, K Arbour, J Lin, A Vajdi, M Tolstorukov, L Hong, J Zhang, ...
JOURNAL OF THORACIC ONCOLOGY 16 (3), S341-S341, 2021
42021
The system can't perform the operation now. Try again later.
Articles 1–20